MSS2020

TBD (2-6 November 2020 or 14-18 June 2021)

PORTOROZ, SLOVENIA

COVID-19 TAKING ITS TOLL ON MSS2020. We must sadly inform you that the pandemic has greatly affected the organization of this years’ MSS2020. Since the health and safety of all of us comes first, we decided to move the conference to a later date. We already have two dates available: 2—6 November 2020 or June 2021. The final decision about the new dates will depend upon the course of the Covid-19 situation.

However, it is still our sincere pleasure to invite you to MSS2020, the 9th Monolith Summer Symposium. MSS2020 will mark some changes in the series. The evolution of monolith technology will continue to be an important element but increased emphasis will be placed on applications; from development to clinical trials to manufacturing. Oral presentations will be coordinated with wet-lab tutorial sessions, highlighting the special abilities of monoliths as analytical and preparative tools in the challenging field of gene therapy.

Featuring talks from

Andrew Knudten

Gene Therapy Consulting LLC, USA

Building a scalable and sustainable commercial manufacturing platform for gene therapies

Venkata Indurthi

Aldevron, USA

Improvements in biologics purification strategies by using monoliths: DNA and RNA perspective

Robert Hodge

Avexis, USA

Development of AAV Based Therapies – Prioritization of Effort

Thomas Linke

AstraZeneca, USA

Developing an Anion Exchange Chromatography (AEX) Assay for Determining Empty and Full Capsid Contents in AAV6.2

Helena Pudilova

Gyroscope Therapeutics Limited, UK

Scalable AAV downstream platform development approaches to support early clinical supply

Steven M. Cramer

Rensselaer Polytechnic Institute, USA

Using monolithic columns to improve mRNA purification efficiency

Bernd Giebel

University Hospital Essen, Germany

Mesenchymal stem/stromal cell-derived extracellular vesicle, a potential new tool in regenerative medicine

Jordan Turnbull

Boehringer Ingelheim, Austria

Purification and concentration of enveloped oncolytic viruses using monolith technology

Lorena Zentilin

International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy

AAV vectors for cardiac protection and regeneration

Simon Staubach

University Hospital Essen, Germany

Monitoring the functionality and integrity of EVs during the purification process

Richard Truran

Biogen, UK

Development of a chromatography-based AAV purification process capable of enriching for full particles

Guenter Allmaier

Medical University of Vienna

Human Rhinovirus: Purification by monolithic chromatography followed by sizing/molecular mass determination by nano electrospray differential mobility analysis

Last chance to get your early tickets
Online registration

You need to complete an online form to register for the conference. Click below to access the form.

Abstract submission

We would like to take this opportunity to invite people from academia and industry to share their knowledge and experience with monolith technology by submitting proposals.

Event timetable

Program
The venue

MSS2020 will be held in Portoroz (Slovenia), a small city on the seaside. You will be able to book a room in different hotels with a special MSS2020 discount.